Mindanao State University – Iligan Institute of Technology Student: _________________________

COLLEGE OF NURSING Block:___________

PHARMACOLOGICAL MANAGEMENT

DRUG STUDY

Brand Name: _____________________Kalcinate____________ Generic Name: ___________Calcium Glucoante__________________ Drug Classification: Electrolytand
replacement solution

Dosage, Route & Frequency Drug-Drug & Adverse

Side Effects
Drug Action Drug-Food Indications Contraindications Reactions (By
Recommended Prescribed (By System)
Interactions System)
Contains 90 mg or 4.5 9% Ca or 4.5 mEq/g Calcium is an Drug-Food: Cereals, PO, IV: Treatment and Hypercalcemia; Renal CNS: tingling CV: bradycardia,
mEq of elemental essential element spinach, orrhubarb prevention of calculi; Ventricular sensation arrhythmia, cardiac
calcium/g for regulating the may decrease the hypocalcemia. PO: fibrillation; Concurrent arrest.
excitation threshold absorption of Adjunct in the use of calcium CV: mild drop of BP
of nerve muscle, calcium supplement prevention of supplements (calcium F & E: hypercalcemia
GI: irritation,
cardiac function, postmenopausal acetate).
Injection: 10% Drug-Drug: constipation,
maintenance of osteoporosis. IV:
solution in 10-ml Hypercalcemia Use Cautiously in: nausea, vomiting,
renal function. Emergency treatment
ampules and vials, 10 increase the risk of Patients receiving thirst, abdominal
of hyperkalemia and
ml or 50 ml vials Replaces calcium digoxin toxicity. digitalis glycosides; pain
hypermagnesemia
and maintains Chronic use with and adjunct in cardiac Severe respiratory
Powder for oral
calcium leve. antacids in renal arrest or calcium insufficiency; Renal
suspension 15 ml
insufficiency may channel blocking disease; Cardiac
Tablets: 500 mg, 650 lead to milk-alkali agent toxicity disease; OB:
ml, 1 g syndrome. (calcium chloride, Hypercalcemia may
calcium gluconate increase risk of
Excessive amounts maternal and fetal
may decrease the complications;
effects of calcium Lactation: Breast
channel blockers. feeding not expected
to harm infant
Calcium
provided that serum
supplements,
calcium levels
including calcium-
containing antacids,
 may increase risk of monitored.
hypercalcemia; avoid
concurrent use.

Responsibilities in the Nursing Process (ADPIE) Responsibilities in the Nursing Process (ADPIE)
ASSESSMENT IMPLEMENTAITON

 Assess IV site for patency.
 Monitor BP, pulse, and ECG frequently throughout parenteral therapy. May cause
vasodilation with resulting hypotension, bradycardia, arrhythmias, and cardiac
arrest.
 Monitor serum calcium or ionized calcium, chloride, sodium, potassium,
magnesium, albumin, and parathyroid hormone (PTH) concentrations before and
periodically during therapy for treatment of hypocalcemia.
EVALUATION
DIAGNOSIS
 Imbalanced nutrition: less than body requirements (Indications)
 Risk for injury related to osteoporosis or electrolyte imbalance (Indications)
 IV Push: Administer slowly by IV push. Rate: Maximum administration rate for adults
is 1.5– 2 mL/ min.
 Continuous Infusion: May be further diluted in 1000 mL of D5W, D10W, D20W,
D5/0.9% NaCl, 0.9% NaCl, D5/LR, or LR.
 Rate: Administer at a rate not to exceed 200 mg/ min over 12– 24 hr
 Monitor electrolyte level throughout therapy.
 Increase in serum calcium levels.
 Decrease in the signs and symptoms of hypocalcemia

PLANNING

 Patient’s calcium level will increase as evidence by laboratory result.

In Patient will display decrease in signs and symptoms of hypocalcemia.
 Mindanao State University – Iligan Institute of Technology Student: _________________________
COLLEGE OF NURSING Block:___________

PHARMACOLOGICAL MANAGEMENT

DRUG STUDY

Brand Name: ____________________Lasix________ Generic Name: ______________Furosemide_______________ Drug Classification:__________Diuretics___________

Dosage, Route & Frequency Drug-Drug & Adverse

Side Effects
Drug Action Drug-Food Indications Contraindications Reactions (By
Recommended Prescribed (By System)
Interactions System)
EDEMA: M, IV Inhibits the Increase risk of Edema due to heart Hypersensitivity; CNS: blurred vision, DERM: erythema,
(Adults): 20– 40 mg, reabsorption of hypotension with failure, hepatic Cross-sensitivity with dizziness, headache, stevens-johnson
may repeat in 1– 2 hr sodium and chloride anti-hypertensives, impairment, or renal thiazides and vertigo syndrome, toxic
and increase by 20 from the loop of nitrates, or acute disease. sulfonamides may epidermal necrolysis
mg every 1– 2 hr until Henle and distal ingestion of alcohol. Hypertension. occur; Hepatic coma or CV: hypotension
response is obtained, renal tubule. Increase risk of anuria; Some liquid HEMAT: aplastic
maintenance dose Increases renal hypokalemia with products may contain GI: anorexia, anemia,
may be given q 6– 12 excretion of water, other diuretics, alcohol, avoid in constipation, dry agranulocytosis
hr; Continuous sodium, chloride, amphotericin B, patients with alcohol mouth, diarrhea
infusion—Bolus 0.1 magnesium, stimulant laxatives, intolerance
mg/kg followed by potassium, and and corticosteroids.
0.1 mg/kg/hr, double calcium. Hypokalemia may
q 2 hr to a maximum Effectiveness increase risk of
of 0.4 mg/ kg/hr. persists in impaired digoxin toxicity and
renal function increase risk of
HYPERTENSION arrhythmia in
PO (Adults): 40 twice patients taking drugs
daily initially (when that prolong
added to regimen,
decrease dose of
other
antihypertensives by
50%); adjust further
dosing based on
response.
 Responsibilities in the Nursing Process (ADPIE) Responsibilities in the Nursing Process (ADPIE)
ASSESSMENT PLANNING
 Assess fluid status.  Patient will be able to have an increase of urinary output, decrease in edema
 Assess vs and BP.
 Assess patients receiving digoxin for anorexia, nausea, vomiting, muscle IMPLEMETATION
cramps, paresthesia, and confusion.  PO: May be taken with food or milk to minimize gastric irritation. Tablets may
 assess for allergy to sulfonamides. be crushed if patient has difficulty swallowing.
DIAGNOSIS  Do not administer discolored solution or tablets.
 Excess fluid volume (Indications)  IV Push: Diluent: Administer undiluted (larger doses may be diluted and
 Deficient fluid volume (Side Effects) administered as intermittent infusion
EVALUATION
 Decrease in edema, BP.
 Increase in urinary output.